Forensic Science Grad Now Working for Pfizer
To say that Harry Jawanda has been busy since graduating from Seton Hill University would be an understatement.
A 2016 graduate from Toronto, Canada, Harry earned a forensic science degree at Seton Hill and was a member of the men’s soccer team.
“Coming from a different country is always going to be a challenge for anyone, but there were many students coming from a similar scenario,” he said about finding a home on the Hill. “I really did appreciate the transparency provided by the professors and the coaching staff on the men’s soccer team.”
“I believe time management, discipline and consistency were the most important traits that I took away from Seton Hill University.”
“Closer to the end of my university career and another step closer to my professional career," he continued, "just as much pertinent guidance was provided by the multitude of resources from internships, research opportunities, professional career advice, and networking I did along the way.”
Being a student in the school of Natural & Health Sciences and a student-athlete for four years while at Seton Hill University helped Harry to become well-equipped for his future career path. “Learning how to juggle both my science-focused academics and athletics at a high level was a very important goal for me,” he said. “I believe time management, discipline and consistency were the most important traits that I took away from Seton Hill University.”
Since graduating, Harry has held multiple roles within different companies. “It feels like a decade since I graduated from Seton Hill due to all of the experience that I have gained in my short career thus far,” he said. Harry moved to different roles involving quality and operations in the healthcare industry, at companies such as Baxter International and Therapure BioPharma in Canada. He has since moved back to the United States to work for Pfizer, acting as a consultant and supporting the largest pharmaceutical manufacturer of sterile injectable controlled substances in the USA on their FDA remediation project.